Closed tender

Pharmacogenomics Testing in Primary Care Consultants

Details

Value
GBP 35,000
Published
13 August 2025
Submission
1 September 2025

Tender description

The project requires expertise from clinicians, academics, industry or other stakeholders who have already led the implementation of pharmacogenomic testing in UK and/ or Ireland to provide support on workable strategies and solutions to design a working pharmacogenomic service on a multinational / multiregional basis. The project will require support on issues (though not an exhaustive list) such as test quality and accreditation standards, compliance with regulatory, ethical, governance and GDPR requirements, genomic data standards, data storage requirements and importantly integration with clinical decision support systems. The project will benefit from training on design, implementation, stress testing and use of an integrated and interoperable pharmacogenomic test service. The pharmacogenomic test service aims to be implemented via regional pilots/ logistics and service testing up to 1st March 2026

Timeline

  1. Completed: Tender published13 August 2025
    Current notice
  2. Completed: Submission date1 September 2025

About the buyer

Ulster University is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.